1-5 of 5
Paul Brennan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-036: A deep learning alternative to regional molecular testing for HPV status

Free
Stephanie G. Craig, Richard Gault, Kristopher D. McCombe, Andrew Moyes, Youcheng Sun, Tao Wang, Andrew Schache, Terry M. Jones, Janet M. Risk, Philip Gunning, Valerie Gaborieau, Paul Brennan, Behnoush Abedi-Ardekani, Jacqueline A. James
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-036.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-036
Published: 15 September 2023
View article titled, Abstract PO-036: A deep learning alternative to regional molecular testing for HPV status
Journal Articles

Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma

Open Access
Naveen S. Vasudev, Ghislaine Scelo, Kate I. Glennon, Michelle Wilson, Louis Letourneau, Robert Eveleigh, Nazanin Nourbehesht, Madeleine Arseneault, Antoine Paccard, Lars Egevad, Juris Viksna, Edgars Celms, Sharon M. Jackson, Behnoush Abedi-Ardekani, Anne Y. Warren, Peter J. Selby, Sebastian Trainor, Michael Kimuli, Jon Cartledge, Naeem Soomro, Adebanji Adeyoju, Poulam M. Patel, Magdalena B. Wozniak, Ivana Holcatova, Antonin Brisuda, Vladimir Janout, Estelle Chanudet, David Zaridze, Anush Moukeria, Oxana Shangina, Lenka Foretova, Marie Navratilova, Dana Mates, Viorel Jinga, Ljiljana Bogdanovic, Bozidar Kovacevic, Anne Cambon-Thomsen, Guillaume Bourque, Alvis Brazma, Jörg Tost, Paul Brennan, Mark Lathrop, Yasser Riazalhosseini, Rosamonde E. Banks
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1220–1231.
https://doi.org/10.1158/1078-0432.CCR-22-1936
Published: 03 April 2023
View article titled, Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
Open the PDF for Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case–Control Study

Free
Ghislaine Scelo, David C. Muller, Elio Riboli, Mattias Johansson, Amanda J. Cross, Paolo Vineis, Konstantinos K. Tsilidis, Paul Brennan, Heiner Boeing, Petra H.M. Peeters, Roel C.H. Vermeulen, Kim Overvad, H. Bas Bueno-de-Mesquita, Gianluca Severi, Vittorio Perduca, Marina Kvaskoff, Antonia Trichopoulou, Carlo La Vecchia, Anna Karakatsani, Domenico Palli, Sabina Sieri, Salvatore Panico, Elisabete Weiderpass, Torkjel M. Sandanger, Therese H. Nøst, Antonio Agudo, J. Ramón Quirós, Miguel Rodríguez-Barranco, Maria-Dolores Chirlaque, Timothy J. Key, Prateek Khanna, Joseph V. Bonventre, Venkata S. Sabbisetti, Rupal S. Bhatt
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (22): 5594–5601.
https://doi.org/10.1158/1078-0432.CCR-18-1496
Published: 15 November 2018
View article titled, KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case–Control Study
Open the PDF for KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case–Control Study in another window
Includes: Supplementary data
Journal Articles

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

Free
Saman Hewamana, Thet Thet Lin, Chris Jenkins, Alan K. Burnett, Craig T. Jordan, Chris Fegan, Paul Brennan, Clare Rowntree, Chris Pepper
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8102–8111.
https://doi.org/10.1158/1078-0432.CCR-08-1673
Published: 15 December 2008
View article titled, The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine
Open the PDF for The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine in another window
Journal Articles

Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors

Free
Michael L. Nickerson, Erich Jaeger, Yangu Shi, Jeffrey A. Durocher, Sunil Mahurkar, David Zaridze, Vsevolod Matveev, Vladimir Janout, Hellena Kollarova, Vladimir Bencko, Marie Navratilova, Neonilia Szeszenia-Dabrowska, Dana Mates, Anush Mukeria, Ivana Holcatova, Laura S. Schmidt, Jorge R. Toro, Sara Karami, Rayjean Hung, Gary F. Gerard, W. Marston Linehan, Maria Merino, Berton Zbar, Paolo Boffetta, Paul Brennan, Nathaniel Rothman, Wong-Ho Chow, Frederic M. Waldman, Lee E. Moore
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4726–4734.
https://doi.org/10.1158/1078-0432.CCR-07-4921
Published: 01 August 2008
View article titled, Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Open the PDF for Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors in another window
Includes: Supplementary data